Rockwell Medical (RMTI) Interest & Investment Income (2010 - 2026)
Rockwell Medical (RMTI) posted Interest & Investment Income of $37000.0 for Q1 2026, down 15.91% on a QoQ basis from $44000.0 in Q4 2025, and down 43.94% year-over-year from $66000.0 in Q1 2025.
Rockwell Medical (RMTI) Interest & Investment Income (2010 - 2026) Analysis & Trends
Rockwell Medical's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $37000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 43.94% year-over-year to $37000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205000.0 (up 52.99% YoY) and the FY2025 annual result came in at $234000.0, up 154.35% from the prior year.
- Interest & Investment Income was $37000.0 for Q1 2026 at Rockwell Medical, down from $44000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $69000.0 in Q2 2025 and bottomed at -$6000.0 in Q3 2022.
- A 5-year average of $40733.3 and a median of $43000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 1033.33% — and 2024, when it sank 81.63%.
- Rockwell Medical's Interest & Investment Income stood at $43000.0 in 2022, then declined by 2.33% to $42000.0 in 2023, then slumped by 30.95% to $29000.0 in 2024, then jumped by 51.72% to $44000.0 in 2025, then fell by 15.91% to $37000.0 in 2026.
- Business Quant data shows RMTI's Interest & Investment Income at $37000.0 in Q1 2026, $44000.0 in Q4 2025, and $55000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn | 37,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 2,000.00 |